Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA IT Infrastructure Inadequate For Managing Foreign Inspections, GAO Says

Executive Summary

FDA's ability to oversee drug importation is encumbered by an inaccurate and dysfunctional information technology infrastructure, the Government Accountability Office asserts

You may also be interested in...



FDA’s Dubious Honor: GAO Flags Many Of Its Activities As “High Risk”

FDA's White Oak campus is still far from complete, but an extreme reading of official statements during the last few weeks might suggest that it could be closed

FDA’s Dubious Honor: GAO Flags Many Of Its Activities As “High Risk”

FDA's White Oak campus is still far from complete, but an extreme reading of official statements during the last few weeks might suggest that it could be closed

FDA Ups Foreign Inspections In FY ’07; Visits 11% Of Foreign Establishments

FDA inspected more foreign drug establishments in fiscal 2007 than in each of the five previous years, but visited less than 11 percent of such facilities, the Government Accountability Office estimates in a report released Oct. 22

Related Content

UsernamePublicRestriction

Register

PS048968

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel